[1] Liu Y, Xu L. Research progress of miRNA in glioma [J].Chinese Journal of New Clinical Medicine, 2018,11(11):1163-1167.(in Chinese)
刘艳,许路. miRNA在神经胶质瘤中作用的研究进展[J]. 中国临床新医学,2018, 11(11):1163-1167.
[2] de Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis[J]. Neuro Oncol,2015,17(6):776-783.
[3] Onishi M, Ichikawa T, Kurozumi K, et al. Angiogenesis and invasion in glioma[J]. Brain Tumor Pathol, 2011, 28(1):13-24.
[4] Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblas tomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis [J]. Clin Oncol, 2005,23(10):2411-2422.
[5] Jin Y, Liang ZQ, Lou HQ. The emerging roles of fox family transcription factors in chromosome replication, organization, and genome stability[J]. Cells, 2020, 9(1):258.
[6] Ye H, Duan M. FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial-mesenchymal transition through regulation of SLUG [J]. Cancer Manag Res, 2019,11(1):525-535.
[7] He W, Kang Y, Zhu W, et al. FOXF2 acts as a crucial molecule in tumours and embryonic development[J]. Cell Death Dis, 2020,116(6):424-434.
[8] Dou C, Jin X,Sun L, et al.FOXF2 deficiency promotes hepatocellular carcinoma metastasis by incliding mesenchymal-epithelial transition[J]. Cancer Biomark, 2017, 19(4):447-454.
[9] Markouli M, Strepkos D, Papavassiliou KA, et al. Bivalent genes targeting of glioma heterogeneity and plasticity[J]. Int J Mol Sci, 2021,22(2):540-563
[10] Li ChF, Jing W, Xiang DSh, et al. Expression of microRNA613 in human glioma and its effects on growth and metastasis[J]. Acta Anatomica Sinica,2018,49(5):579-583. (in Chiese)
李传芬,荆文,向冬生,等. MicroRNA-613在人胶质瘤中的表达及其对增殖与转移的影响[J].解剖学报,2018,49(5):579-583.
[11] Ramezani A, Nikravesh H, Faghihloo E. The roles of FOX proteins in virus-associated cancers [J].J Cell Physiol, 2019, 234(4):3361-3374.
[12] Schuff M, Rossner A, Donow C, et al. Temporal and spatial expressionpatterns of FoxN genes in Xenopus laevis embryos[J]. Int J Dev Biol,2006,50(4):429-434.
[13] Rho HK, McClay DR. The control of foxN2/3 expression in sea urchin embryos and its function in the skeletogenic gene regulatory network [J]. Development,2011, 138(1):937-945.
[14] Nagel S, Pommerenke C, Meyer C, et al. Identification of a tumor suppressor network in T-cell leukemia[J]. Leuk Lymphoma, 2017, 58(9):2196-2207.
[15] Ma J, Lu Y, Zhang S, et al. β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer[J]. Cell Death Differ, 2018,25(8):1473-1485.
[16] Robertson E, Perry C, Doherty R, et al. Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme [J]. Cancer Genomics Proteomics, 2015,12(3):103-112.
[17] Zhang J, Zhang C, Sang L, et al. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway [J]. Biosci Rep, 2018, 385(5):747-757.
[18] Wang A, Jin C, Li H, et al. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-18-5p/FOXF2 signaling pathway[J]. Int J Biol Macromol, 2018,120(Pt B):1705-1713.
[19] Higashimori A, Dong Y, Zhang Y, et al. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-β-catenin signaling axis [J]. Cancer Res, 2018, 787(7):1643-1656.
[20] Wei WR, Zeng GJ, Liu C, et al. Overexpression of miR-96 promotes cell proliferati on by targeting FOXF2 in prostate cancer [J]. Int J Clin Exp Pathol, 2017,107(7): 7596-7602.
[21] Chen W, Tong K, Yu J. MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2 [J]. Mol Med Rep, 2017,164(4):5241-5248.
[22] Zheng YZ, Wen J, Cao X, et al. Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma [J]. Mol Clin Oncol, 2015,33(3):713-719.
[23] Yamashita H, Amponsa VO, Warrick JI, et al. On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer[J]. Nat Rev Urol, 2017,142(2):98-106.
[24] van den Brink GR, Rubin DC. Foxf2: a mesenchymal regulator of intestinal adenoma development [J]. Gastroenterology, 2013,144(5):873-876.
|